Peptides work best as enhancement to already-solid fundamentals, not as substitutes for them
Semaglutide, a GLP-1 receptor agonist, has emerged as a powerful tool for weight management, with clinical trials demonstrating average weight loss of 1522% over 68 weeks
From the PlexusDx Education Hub: a look at how one telehealth brand prescribes and dispenses semaglutide, and what that means before you enroll
This helps ensure you wont run out of medication and keeps you in touch with your care team to monitor your progress and encourage you on your path to a healthier weight
McDonalds, the worlds largest fast-food chain, claims that it has not yet seen an impact on their business due to GLP-1 drugs, but acknowledges that future impact is uncertain
Mosenzon O, Aroda VR, Christiansen E, Harris SB, Boje Pedersen K, Tarp-Johansen MJ, et al